Oncology Letters · 2020 · 16 citations · 32 references
Life SciencesMolecular BiologyOncologyGene ExpressionMolecular OncologyTumor ProgressionMicrorna BiologyMicrorna-mediated RegulationNotch SignalingOncogenic Signaling PathwaysOvarian CancerSignal Transduction In CancerExosomal Noncoding RnaMicrorna Function In CancerMicrorna In CancerMicrorna ModulationMicrorna Regulation In CancerMicrorna Regulation Of EmtOvarian Cancer PathogenesisOvarian Cancer Treatment
Exosomal microRNA (miR) can affect signaling pathways in various physiological and pathological conditions, including ovarian cancer (OC). miR-34b, the first microRNA targeted in a human clinical trial for cancer treatment, exhibited decreased expression in several cancer types. However, the biological function of exosomal miR-34b in OC has not been elucidated. In the present study, using reverse transcription-quantitative PCR, it was reported that exosomal miR-34b is downregulated in OC cells. Exosomal miR-34b reduced cell proliferation and epithelial-mesenchymal transition (EMT) in the OC cell line SKOV3. In addition, it was confirmed that Notch2, which is upregulated in SKOV3 cells, is a target of miR-34b. Moreover, exosomal miR-34b and Notch2 levels were found to be negatively correlated. The present data highlights the importance of exosomal miR-34b-mediated inhibition of cell proliferation and EMT, suggesting that exosomal miR-34b has value as a diagnostic biomarker and a potential molecular target for the treatment of OC.
32
Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2013 · 11.9K citations · Full text
Rebecca L. Siegel, Elizabeth Ward, Otis W. Brawley et al. · CA A Cancer Journal for Clinicians · 2011 · 4.1K citations · Full text
Adipose-derived circulating miRNAs regulate gene expression in other tissues
Thomas Thomou, Marcelo A. Mori, Jonathan M. Dreyfuss et al. · Nature · 2017 · 1.6K citations · Full text
Kaladhar B. Reddy · Cancer Cell International · 2015 · 612 citations · Full text